Using bioinformatics methods such as GSEA, TIDE, ESTIMATE, and ssGSEA, we confirmed that CXCL12 is an unfavorable prognostic factor in the progression of BLCA. This evidence concerns the gene CXCL12 and bladder transitional cell carcinoma.